Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Hehlmann R, Hochhaus A, Baccarani M . Chronic myeloid leukaemia. Lancet 2007; 370: 342–350.

    Article  CAS  Google Scholar 

  2. McNally RJ, Rowland D, Roman E, Cartwright RA . Age and sex distributions of hematological malignancies in the U. K. Hematol Oncol 1997; 15: 173–189.

    Article  CAS  Google Scholar 

  3. Krebsregister Saarland, Germany. http://www.krebsregister.saarland.de.

  4. Swedish Cancer Registry. 1998–2006, Annual report publications of the Centre of Epidemiology at the National Board of Health and Welfare. http://www.socialstyrelsen.se/Statistik/statistik_amne/Cancer.

  5. Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ et al. SEER Cancer Statistics Review, 1975–2005. U.S. National Cancer Institute: Bethesda. http://www.seer.cancer.gov/csr/1975_2005/.

  6. Harrison SJ, Johnson PRE, Holyoake TL . The Scotland Leukaemia Registry audit of incidence, diagnosis and clinical management of new patients with chronic myeloid leukaemia in 1999 and 2000. Scott Med J 2004; 49: 87–90.

    Article  CAS  Google Scholar 

  7. Berger U, Maywald O, Pfirrmann M, Lahaye T, Hochhaus A, Reiter A et al. Gender aspects in chronic myeloid leukemia: long-term results from randomized studies. Leukemia 2005; 19: 984–989.

    Article  CAS  Google Scholar 

  8. Ridell B, Carneskog J, Wedel H, Vilen L, Hogh Dufva I, Mellqvist UH et al. Incidence of chronic myeloproliferative disorders in the city of Göteborg Sweden 1983–1992. Eur J Haematol 2000; 65: 267–271.

    Article  CAS  Google Scholar 

  9. Hasford J, Baccarani M, Hehlmann R, Ansari H, Tura S, Zuffa E. Interferon-alpha and hydroxyurea in early chronic myeloid leukemia: a comparative analysis of the Italian German chronic myeloid leukemia trials with interferon-a. Blood 1996; 88: 5384–5391.

    Google Scholar 

Download references

Acknowledgements

This study was supported by the German José-Carreras-Leukämie-Stiftung e.V. (DJCLS-R5) and by the Bundesministerium für Bildung und Forschung, Germany, via the Competence Network ‘Akute und chronische Leukämien’ and sponsored by the Bundesministerium für Bildung und Forschung, Germany.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Rohrbacher.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rohrbacher, M., Berger, U., Hochhaus, A. et al. Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany. Leukemia 23, 602–604 (2009). https://doi.org/10.1038/leu.2008.245

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/leu.2008.245

This article is cited by

Search

Quick links